RedHill Biopharma hält Präsentation auf Deutschem Eigenkapitalforum 2020
November 16, 2020 09:27 ET
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel und RALEIGH, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) („RedHill“ oder das „Unternehmen“), ein spezialisiertes biopharmazeutisches Unternehmen,...
RedHill Biopharma to Present at German Equity Forum 2020
November 13, 2020 07:00 ET
|
RedHill Biopharma Ltd.
TEL AVIV, Israel and RALEIGH, N.C., Nov. 13, 2020 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that...
RedHill Biopharma Provides Q3/2020 Results and Highlights, Including 300% Talicia Prescription Growth
November 12, 2020 07:00 ET
|
RedHill Biopharma Ltd.
Q3/2020 net revenues of approximately $21 million, with gross profit of $10.6 million, or approximately 51%, up from $6.7 million and approximately 32% in Q2/2020--Strong growth for Talicia® with...
RedHill Biopharma to Host Third Quarter Financial Results and Business Highlights Webcast on November 12, 2020
November 05, 2020 07:00 ET
|
RedHill Biopharma Ltd.
TEL AVIV, Israel and RALEIGH, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that...
RedHill Biopharma Presents New Data from Talicia®’s Phase 3 Studies at ACG 2020 Focused on Achieving Successful First-Line Treatment in H. pylori Eradication
October 26, 2020 09:00 ET
|
RedHill Biopharma Ltd.
H. pylori eradication rates with clarithromycin-based triple therapy were found to be predictably low in the Phase 3 trial, with antibiotic resistance a contributing factor. Despite declining...
RedHill Biopharma annonce des partenariats visant à augmenter la fabrication de l'opaganib, candidat thérapeutique pour le traitement du COVID-19
October 15, 2020 01:00 ET
|
RedHill Biopharma Ltd.
Les collaborations avec des fournisseurs européens et canadiens pour une montée en puissance à grande échelle de la fabrication de l'opaganib renforcent davantage les capacités de fabrication, en...